細胞分析市場：製品・サービス（試薬・消耗品、装置）、技術（フローサイトメトリー、ハイコンテントスクリーニング）、プロセス（単一細胞分析）、エンドユーザー（製薬会社、バイオテクノロジー会社）別 - 2027年までの世界予測

Cell Analysis Market by Product & Service (Reagents & Consumables, Instruments), Technique (Flow Cytometry, High Content Screening), Process (Single-cell Analysis), End User (Pharmaceutical and Biotechnology Companies) - Global Forecast to 2027

細胞分析の世界市場は、2022年の177億米ドルから2027年には286億米ドルに達すると予測され、予測期間中のCAGRは10.1%となります。細胞分析市場の主な機会としては、新興国、伝染病やパンデミック発生のリスクの高... もっと見る

出版社	出版年月	電子版価格	ページ数	図表数	言語
MarketsandMarkets マーケッツアンドマーケッツ	2022年5月31日	US$4,950 シングルユーザライセンスライセンス・価格情報注文方法はこちら	228	274	英語

日本語のページは自動翻訳を利用し作成しています。

サマリー

細胞分析の世界市場は、2022年の177億米ドルから2027年には286億米ドルに達すると予測され、予測期間中のCAGRは10.1%となります。細胞分析市場の主な機会としては、新興国、伝染病やパンデミック発生のリスクの高さ、さまざまな癌研究アプリケーションにおける新しい細胞アッセイの採用の増加などが挙げられます。一方、細胞分析装置に関するコストの高さや、実験に使用する試薬の制限などが、市場の成長を抑制する要因になると予想されます。

"2020-2027年の調査期間を通じて、試薬・消耗品セグメントが細胞分析市場を支配している"

世界の細胞分析市場は、製品・サービスに基づいて、試薬＆消耗品、機器、アクセサリー、ソフトウェア、サービスに区分されます。試薬・消耗品セグメントは、2021年の細胞分析市場において最大の市場シェアを占めています。主要な市場プレーヤーによる手頃な価格の試薬ソリューションの開発が、このセグメントの優位性の主な要因となっています。さらに、フローサイトメトリー実験における新規の細胞分析試薬＆消耗品に対する需要の増加が、これを補完している。

"ハイコンテンツスクリーニング（HCS）セグメントは、予測期間中に細胞分析市場で最も高い成長を目撃するでしょう。"

世界の細胞分析市場は、技術に基づき、フローサイトメトリー、PCR、セルマイクロアレイ、顕微鏡、分光光度計、ハイコンテンツスクリーニング（HCS）、その他の技術に区分されます。HCSは、高スループットの自動イメージングと、マルチパラメトリックな単一細胞データの抽出を支援する分析を組み合わせた技術です。さらに、HCSの用途が広がっていることが、2022年から2027年にかけてこのセグメントが記録した強固なCAGRに寄与しています。

"2021年、北米が細胞分析市場を支配"
地域的には、細胞分析市場は、北米、欧州、アジア太平洋、中南米、中東・アフリカに区分されます。2021年、北米は細胞分析市場の最大のシェアを占めました。北米は主要な市場プレイヤーの大半を抱え、同地域の細胞分析市場の成熟に繋がっています。また、学術・研究活動に対する政府の強力な支援は、主要な市場プレーヤーが最先端の細胞分析製品を導入する機会を提供し、地域市場の競争をさらに激化させています。
本レポートのために実施した主要インタビューは、以下のように分類されます。
- 企業タイプ別 - ティア1：37％、ティア2：23％、ティア3：40
- 役職別：Cレベル：32％、Dレベル：26％、その他：42
- 地域別：北米35％、欧州25％、アジア太平洋20％、中南米12％、中近東・アフリカ8
レポート掲載企業一覧
- ダナハー（米国）
- サーモフィッシャーサイエンティフィック（米国）
- ベクトン・ディッキンソン＆カンパニー（米国）
- ゼネラル・エレクトリック（米国）
- メルクKGaA（米国）
- アジレント・テクノロジー (米国)
- オリンパス株式会社 (日本)
- ミルテニーバイオテック (米国)
- バイオ・ラッド・ラボラトリーズ (米国)
- バイオステータス・リミテッド (英国)
- フルイディグム・コーポレーション（米国）
- ナノセレクトバイオメディカル（米国）
- セルバイオラボ（米国）
- クリエイティブバイオアレイ（米）
- 明治テクノ（米国）
- プロメガコーポレーション (米)
- パーキンエルマー社（米国）
- テカントレーディング株式会社 (スイス)
- CELLINK社（米国）
- QIAGEN (ドイツ)
- コーニング・インコーポレイテッド（米国）
- 10x Genomics社（米国）
- イルミナ（米国）

調査対象
本レポートは、世界の細胞分析市場の詳細な状況を提供します。製品・サービス、技術、プロセス、エンドユーザー、地域など、さまざまなセグメントにおける市場規模と今後の成長可能性を推定することを目的としています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会など）を分析しています。利害関係者にとっては市場の機会を評価し、市場リーダーにとっては競争環境の詳細を提供します。また、マイクロマーケットについて、その成長動向、展望、細胞分析市場全体への貢献度に関しても調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。

レポートを購入する理由
本レポートは、以下のポイントに関する洞察を提供しています。
- 市場の浸透。細胞分析市場の上位25社が提供する細胞分析に関する包括的な情報。細胞分析市場を製品・サービス、技術、プロセス、エンドユーザー、地域別に分析しています。

- 市場開拓。有利な新興市場に関する包括的な情報です。本レポートでは、主要な地域ごとの様々な細胞解析の市場を分析しています。

- 市場の多様化。細胞分析市場における新製品、未開拓の地域、最近の開発、投資に関する情報を網羅的に提供します。

- 競争力の評価。細胞分析市場における主要企業の市場ランキングと戦略に関する詳細な評価。

ページTOPに戻る

1 INTRODUCTION 32
1.1 OBJECTIVES OF THE STUDY 32
1.2 MARKET DEFINITION 32
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 33
1.2.2 MARKETS COVERED 33
1.2.3 YEARS CONSIDERED FOR THE STUDY 34
1.3 CURRENCY 34
1.4 LIMITATIONS 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 38
FIGURE 2 CELL ANALYSIS MARKET: BREAKDOWN OF PRIMARIES 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP (SUPPLY SIDE) 39
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS, 2020 39
FIGURE 5 AVERAGE MARKET SIZE ESTIMATION (2021) 40
2.3 GROWTH RATE ASSUMPTIONS/GROWTH FORECAST 41
FIGURE 6 CELL ANALYSIS MARKET: CAGR PROJECTIONS (2022–2027) 42
FIGURE 7 CELL ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS,
RESTRAINTS, AND OPPORTUNITIES 42
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 44
FIGURE 8 DATA TRIANGULATION METHODOLOGY 44
2.5 INSIGHTS FROM PRIMARIES 45
FIGURE 9 MARKET VALIDATION FROM PRIMARY EXPERTS 45
2.6 RESEARCH ASSUMPTIONS 45
2.6.1 COVID-19-SPECIFIC ASSUMPTIONS 46
2.7 RISK ANALYSIS 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2022 VS. 2027 (USD MILLION) 47
FIGURE 11 CELL ANALYSIS MARKET, BY TECHNIQUE, 2022 VS. 2027 (USD MILLION) 48
FIGURE 12 CELL ANALYSIS MARKET, BY PROCESS, 2022 VS. 2027 (USD MILLION) 49
FIGURE 13 CELL ANALYSIS MARKET, BY END USER, 2022 VS. 2027 (USD MILLION) 50
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF THE CELL ANALYSIS MARKET 51
4 PREMIUM INSIGHTS 52
4.1 CELL ANALYSIS MARKET OVERVIEW 52
FIGURE 15 INCREASING FUNDING FOR CELL-BASED RESEARCH TO
DRIVE MARKET GROWTH 52
4.2 NORTH AMERICA: CELL ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE
AND COUNTRY (2021) 53
FIGURE 16 REAGENTS & CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 53
4.3 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE,
2022 VS. 2027 (USD MILLION) 54
FIGURE 17 FLOW CYTOMETRY SEGMENT WILL CONTINUE TO DOMINATE
NORTH AMERICAN MARKET IN 2027 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 56
FIGURE 18 CELL ANALYSIS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES 56
TABLE 1 CELL ANALYSIS MARKET: IMPACT ANALYSIS 56
5.2.1 DRIVERS 57
5.2.1.1 Rising preference for cell-based assays in drug discovery 57
5.2.1.2 Increasing funding for cell-based research 57
5.2.1.3 Growing number of drug discovery activities 57
5.2.2 RESTRAINT 58
5.2.2.1 High cost of instruments and restrictions on reagent use 58
5.2.3 OPPORTUNITIES 58
5.2.3.1 Emerging economies 58
5.2.3.2 Growing risk of pandemics and communicable diseases 58
5.2.3.3 Application of novel cell-based assays in cancer research 59
5.3 PORTER’S FIVE FORCES ANALYSIS 59
TABLE 2 CELL ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 59
5.3.1 THREAT OF NEW ENTRANTS 59
5.3.2 THREAT OF SUBSTITUTES 60
5.3.3 BARGAINING POWER OF BUYERS 60
5.3.4 BARGAINING POWER OF SUPPLIERS 60
5.3.5 DEGREE OF COMPETITION 60
5.4 IMPACT OF COVID-19 ON THE CELL ANALYSIS MARKET 60
5.5 SUPPLY CHAIN ANALYSIS 61
FIGURE 19 CELL ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS (CELL-BASED ASSAYS) 62
5.6 VALUE CHAIN ANALYSIS 62
FIGURE 20 CELL ANALYSIS MARKET: VALUE CHAIN ANALYSIS 63
5.7 ECOSYSTEM ANALYSIS 64
FIGURE 21 CELL ANALYSIS MARKET: ECOSYSTEM ANALYSIS 64
5.8 REGULATORY ANALYSIS (FLOW CYTOMETRY-BASED CELL ANALYSIS) 65
5.8.1 STRINGENT FDA REQUIREMENTS 65
5.8.2 STRINGENT ANALYTE-SPECIFIC REAGENT RULE 65
5.8.3 LACK OF WELL-DEFINED VALIDATION PROTOCOLS FOR CELL-BASED ASSAYS 65
5.8.4 ABSENCE OF ESTABLISHED LABORATORY-DEVELOPED TEST GUIDELINES ON CELL-BASED FLUORESCENCE ASSAYS 65
5.8.5 GREATER GLOBAL RECOGNITION FOR IVD CE MARK APPROVALS 66
5.8.6 US REIMBURSEMENT SCENARIO 66
5.9 TECHNOLOGY ANALYSIS 66
FIGURE 22 TECHNOLOGY ANALYSIS: CELL ANALYSIS MARKET 67
5.10 KEY CONFERENCES & EVENTS, 2021–2022 67
5.10.1 CELL ANALYSIS CONFERENCES, 2022 67
TABLE 3 CELL ANALYSIS CONFERENCES (2022) 67
5.10.2 CELL ANALYSIS CONFERENCES, 2021 68
TABLE 4 CELL ANALYSIS CONFERENCES (2021) 68
5.11 PRICING ANALYSIS 68
5.11.1 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS & SERVICES 68
TABLE 5 AVERAGE SELLING PRICES OF CELL ANALYSIS PRODUCTS &
SERVICES (TOP 5) 68
5.11.2 AVERAGE SELLING PRICE TREND 69
6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE 70
6.1 INTRODUCTION 71
TABLE 6 CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 71
6.2 REAGENTS & CONSUMABLES 71
6.2.1 ADVENT OF NOVEL CELL ANALYSIS KITS & REAGENTS FOR FLOW CYTOMETRY TO BOOST SEGMENT GROWTH 71
TABLE 7 CELL ANALYSIS REAGENTS & CONSUMABLES MARKET, BY REGION,
2020–2027 (USD MILLION) 72
TABLE 8 NORTH AMERICA: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 72
TABLE 9 EUROPE: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 73
TABLE 10 ASIA PACIFIC: CELL ANALYSIS REAGENTS & CONSUMABLES MARKET,
BY COUNTRY, 2020–2027 (USD MILLION) 73
6.3 INSTRUMENTS 74
6.3.1 INNOVATIONS IN CELL ANALYSIS INSTRUMENTS FOR DRUG DISCOVERY RESEARCH TO DRIVE MARKET GROWTH 74
TABLE 11 CELL ANALYSIS INSTRUMENTS MARKET, BY REGION,
2020–2027 (USD MILLION) 74
TABLE 12 NORTH AMERICA: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 75
TABLE 13 EUROPE: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 75
TABLE 14 ASIA PACIFIC: CELL ANALYSIS INSTRUMENTS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 75
6.4 ACCESSORIES 76
6.4.1 FLOW CYTOMETRY ACCESSORIES ENABLE END USERS TO CUSTOMIZE
FLOW CYTOMETRY INSTRUMENTS 76
TABLE 15 CELL ANALYSIS ACCESSORIES MARKET, BY REGION,
2020–2027 (USD MILLION) 76
TABLE 16 NORTH AMERICA: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 76
TABLE 17 EUROPE: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 77
TABLE 18 ASIA PACIFIC: CELL ANALYSIS ACCESSORIES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 77
6.5 SOFTWARE 78
6.5.1 EXPANDING POOL OF KEY PLAYERS INTRODUCING UNIQUE SOFTWARE OR DATA INTERPRETATION TOOLS PROPELS SEGMENT GROWTH 78
TABLE 19 CELL ANALYSIS SOFTWARE MARKET, BY REGION,
2020–2027 (USD MILLION) 78
TABLE 20 NORTH AMERICA: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
TABLE 21 EUROPE: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
TABLE 22 ASIA PACIFIC: CELL ANALYSIS SOFTWARE MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 79
6.6 SERVICES 80
6.6.1 REMOTE SERVICES ENSURE WORKFLOW CONTINUITY AND
MAXIMIZE PERFORMANCE 80
TABLE 23 CELL ANALYSIS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 80
TABLE 24 NORTH AMERICA: CELL ANALYSIS SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 80
TABLE 25 EUROPE: CELL ANALYSIS SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 81
TABLE 26 ASIA PACIFIC: CELL ANALYSIS SERVICES MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 81
7 CELL ANALYSIS MARKET, BY TECHNIQUE 82
7.1 INTRODUCTION 83
TABLE 27 CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 83
7.2 FLOW CYTOMETRY 83
7.2.1 ABILITY TO PERFORM MULTIPLE MEASUREMENTS ON SINGLE CELLS IS KEY ADVANTAGE ASSOCIATED WITH THIS TECHNIQUE 83
TABLE 28 CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY REGION,
2020–2027 (USD MILLION) 84
TABLE 29 NORTH AMERICA: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY,
BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 30 EUROPE: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION) 84
TABLE 31 ASIA PACIFIC: CELL ANALYSIS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION) 85
7.3 PCR 85
7.3.1 DIGITAL PCR CAN EFFECTIVELY MEASURE AND MONITOR RARE SEQUENCES 85
TABLE 32 CELL ANALYSIS MARKET FOR PCR, BY REGION, 2020–2027 (USD MILLION) 86
TABLE 33 NORTH AMERICA: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY,
2020–2027 (USD MILLION) 86
TABLE 34 EUROPE: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY,
2020–2027 (USD MILLION) 86
TABLE 35 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PCR, BY COUNTRY,
2020–2027 (USD MILLION) 87
7.4 CELL MICROARRAYS 87
7.4.1 CELL MICROARRAYS ARE USED IN DESIGNING AND CONTROLLING STEM CELLS IN TISSUE ENGINEERING 87
TABLE 36 CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY REGION,
2020–2027 (USD MILLION) 87
TABLE 37 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL MICROARRAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 38 EUROPE: CELL ANALYSIS MARKET FOR CELL MICROARRAYS, BY COUNTRY, 2020–2027 (USD MILLION) 88
TABLE 39 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL MICROARRAYS,
BY COUNTRY, 2020–2027 (USD MILLION) 89
7.5 MICROSCOPY 89
7.5.1 RISING INCIDENCE OF CANCER AND GROWING INVESTMENTS IN
CELL BIOLOGY TO DRIVE MARKET GROWTH 89
TABLE 40 CELL ANALYSIS MARKET FOR MICROSCOPY, BY REGION,
2020–2027 (USD MILLION) 90
TABLE 41 NORTH AMERICA: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION) 90
TABLE 42 EUROPE: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY,
2020–2027 (USD MILLION) 91
TABLE 43 ASIA PACIFIC: CELL ANALYSIS MARKET FOR MICROSCOPY, BY COUNTRY, 2020–2027 (USD MILLION) 91
7.6 SPECTROPHOTOMETRY 92
7.6.1 HIGH DEMAND FOR SPECTROPHOTOMETERS IN RESEARCH SETTINGS TO SUPPORT MARKET GROWTH 92
TABLE 44 CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY REGION,
2020–2027 (USD MILLION) 92
TABLE 45 NORTH AMERICA: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY,
BY COUNTRY, 2020–2027 (USD MILLION) 92
TABLE 46 EUROPE: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY, BY COUNTRY, 2020–2027 (USD MILLION) 93
TABLE 47 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SPECTROPHOTOMETRY,
BY COUNTRY, 2020–2027 (USD MILLION) 93
7.7 HIGH-CONTENT SCREENING (HCS) 94
7.7.1 HIGH DEMAND FOR HCS IN CELL BEHAVIOR RESEARCH STUDIES TO SUPPORT SEGMENT GROWTH 94
TABLE 48 CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY REGION, 2020–2027 (USD MILLION) 94
TABLE 49 NORTH AMERICA: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING, BY COUNTRY, 2020–2027 (USD MILLION) 94
TABLE 50 EUROPE: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2020–2027 (USD MILLION) 95
TABLE 51 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HIGH-CONTENT SCREENING,
BY COUNTRY, 2020–2027 (USD MILLION) 95
7.8 OTHER TECHNIQUES 96
TABLE 52 CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY REGION,
2020–2027 (USD MILLION) 96
TABLE 53 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2020–2027 (USD MILLION) 96
TABLE 54 EUROPE: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2020–2027 (USD MILLION) 97
TABLE 55 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER TECHNIQUES,
BY COUNTRY, 2020–2027 (USD MILLION) 97
8 CELL ANALYSIS MARKET, BY PROCESS 98
8.1 INTRODUCTION 99
TABLE 56 CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 99
8.2 CELL IDENTIFICATION 99
8.2.1 INCREASING RESEARCH ACTIVITIES TO PROPEL MARKET GROWTH 99
TABLE 57 CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY REGION,
2020–2027 (USD MILLION) 100
TABLE 58 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION,
BY COUNTRY, 2020–2027 (USD MILLION) 100
TABLE 59 EUROPE: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION, BY COUNTRY, 2020–2027 (USD MILLION) 101
TABLE 60 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL IDENTIFICATION,
BY COUNTRY, 2020–2027 (USD MILLION) 101
8.3 CELL VIABILITY 102
8.3.1 CELL VIABILITY IS USED TO CORRELATE CELL BEHAVIOR TO CELL NUMBERS 102
TABLE 61 CELL ANALYSIS MARKET FOR CELL VIABILITY, BY REGION,
2020–2027 (USD MILLION) 102
TABLE 62 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 103
TABLE 63 EUROPE: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY,
2020–2027 (USD MILLION) 103
TABLE 64 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL VIABILITY, BY COUNTRY, 2020–2027 (USD MILLION) 104
8.4 CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION 104
8.4.1 HIGH DEMAND FOR TOXICITY TESTING IN DRUG DEVELOPMENT TO DRIVE MARKET GROWTH 104
TABLE 65 CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY REGION, 2020–2027 (USD MILLION) 105
TABLE 66 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY,
2020–2027 (USD MILLION) 105
TABLE 67 EUROPE: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 68 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL SIGNALING PATHWAY/SIGNAL TRANSDUCTION, BY COUNTRY,
2020–2027 (USD MILLION) 106
8.5 CELL PROLIFERATION 107
8.5.1 CELL PROLIFERATION IS MEASURED ON THE BASIS OF
AVERAGE DNA CONTENT 107
TABLE 69 CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY REGION,
2020–2027 (USD MILLION) 107
TABLE 70 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL PROLIFERATION,
BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 71 EUROPE: CELL ANALYSIS MARKET FOR CELL PROLIFERATION, BY COUNTRY, 2020–2027 (USD MILLION) 108
TABLE 72 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL PROLIFERATION,
BY COUNTRY, 2020–2027 (USD MILLION) 109
8.6 CELL COUNTING & QUALITY CONTROL 109
8.6.1 FLOW CYTOMETRY ENABLES EASY DIFFERENTIATION OF CELLS VIA SCATTERING OR STAINING 109
TABLE 73 CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL,
BY REGION, 2020–2027 (USD MILLION) 110
TABLE 74 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 75 EUROPE: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION) 111
TABLE 76 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL COUNTING & QUALITY CONTROL, BY COUNTRY, 2020–2027 (USD MILLION) 111
8.7 CELL INTERACTION 112
8.7.1 INCREASING ADVANCEMENTS IN CELL-CELL INTERACTIONS/CELL-CELL COMMUNICATION TO BOOST MARKET GROWTH 112
TABLE 77 CELL ANALYSIS MARKET FOR CELL INTERACTION, BY REGION,
2020–2027 (USD MILLION) 112
TABLE 78 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL INTERACTION,
BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 79 EUROPE: CELL ANALYSIS MARKET FOR CELL INTERACTION, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 80 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL INTERACTION,
BY COUNTRY, 2020–2027 (USD MILLION) 114
8.8 CELL STRUCTURE STUDY 114
8.8.1 ADVANCEMENTS IN CELLULAR IMAGING TO SUPPORT MARKET GROWTH 114
TABLE 81 CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY, BY REGION,
2020–2027 (USD MILLION) 115
TABLE 82 NORTH AMERICA: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY,
BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 83 EUROPE: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY,
BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 84 ASIA PACIFIC: CELL ANALYSIS MARKET FOR CELL STRUCTURE STUDY,
BY COUNTRY, 2020–2027 (USD MILLION) 116
8.9 TARGET IDENTIFICATION & VALIDATION 117
8.9.1 HCS IN TARGET IDENTIFICATION IS USED TO IDENTIFY NOVEL TARGETS THROUGH SCREENING OF CELLULAR PATHWAYS 117
TABLE 85 CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION,
BY REGION, 2020–2027 (USD MILLION) 117
TABLE 86 NORTH AMERICA: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION) 117
TABLE 87 EUROPE: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 88 ASIA PACIFIC: CELL ANALYSIS MARKET FOR TARGET IDENTIFICATION & VALIDATION, BY COUNTRY, 2020–2027 (USD MILLION) 118
8.10 SINGLE-CELL ANALYSIS 119
8.10.1 EXPANDING APPLICATIONS OF SINGLE-CELL ANALYSIS IN CLINICAL RESEARCH TO PROPEL SEGMENT GROWTH 119
TABLE 89 CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY REGION,
2020–2027 (USD MILLION) 119
TABLE 90 NORTH AMERICA: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS,
BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 91 EUROPE: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS, BY COUNTRY, 2020–2027 (USD MILLION) 120
TABLE 92 ASIA PACIFIC: CELL ANALYSIS MARKET FOR SINGLE-CELL ANALYSIS,
BY COUNTRY, 2020–2027 (USD MILLION) 120
9 CELL ANALYSIS MARKET, BY END USER 121
9.1 INTRODUCTION 122
TABLE 93 CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 122
9.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 122
9.2.1 HIGH DEMAND FOR CELL-BASED RESEARCH IN DRUG DISCOVERY & DEVELOPMENT PROCESS CONTRIBUTES TO SEGMENT GROWTH 122
TABLE 94 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY APPLICATION, 2020–2027 (USD MILLION) 123
TABLE 95 CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2020–2027 (USD MILLION) 124
TABLE 96 NORTH AMERICA: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 124
TABLE 97 EUROPE: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 125
TABLE 98 ASIA PACIFIC: CELL ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020–2027 (USD MILLION) 125
9.3 HOSPITALS & CLINICAL TESTING LABORATORIES 126
9.3.1 DEVELOPMENT OF COMPLEX & HIGHLY SPECIALIZED TESTS AND ASSAYS SUPPORTS MARKET GROWTH 126
TABLE 99 CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY REGION, 2020–2027 (USD MILLION) 126
TABLE 100 NORTH AMERICA: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 101 EUROPE: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 102 ASIA PACIFIC: CELL ANALYSIS MARKET FOR HOSPITALS & CLINICAL TESTING LABORATORIES, BY COUNTRY, 2020–2027 (USD MILLION) 127
9.4 ACADEMIC & RESEARCH INSTITUTES 128
9.4.1 GROWING NUMBER OF RESEARCH PROJECTS THROUGH INDUSTRY-ACADEMIA COLLABORATIONS TO DRIVE MARKET GROWTH 128
TABLE 103 CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES,
BY REGION, 2020–2027 (USD MILLION) 128
TABLE 104 NORTH AMERICA: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 105 EUROPE: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 106 ASIA PACIFIC: CELL ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2020–2027 (USD MILLION) 130
9.5 OTHER END USERS 130
TABLE 107 CELL ANALYSIS MARKET FOR OTHER END USERS, BY REGION,
2020–2027 (USD MILLION) 131
TABLE 108 NORTH AMERICA: CELL ANALYSIS MARKET FOR OTHER END USERS,
BY COUNTRY, 2020–2027 (USD MILLION) 131
TABLE 109 EUROPE: CELL ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 110 ASIA PACIFIC: CELL ANALYSIS MARKET FOR OTHER END USERS,
BY COUNTRY, 2020–2027 (USD MILLION) 132
10 CELL ANALYSIS MARKET, BY REGION 133
10.1 INTRODUCTION 134
TABLE 111 CELL ANALYSIS MARKET, BY REGION, 2020–2027 (USD MILLION) 134
10.2 NORTH AMERICA 134
FIGURE 23 NORTH AMERICA: CELL ANALYSIS MARKET SNAPSHOT 135
TABLE 112 NORTH AMERICA: CELL ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 135
TABLE 113 NORTH AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 136
TABLE 114 NORTH AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 136
TABLE 115 NORTH AMERICA: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 137
TABLE 116 NORTH AMERICA: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 137
10.2.1 US 138
10.2.1.1 US dominates North American cell analysis market 138
TABLE 117 US: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 138
TABLE 118 US: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 139
TABLE 119 US: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 139
TABLE 120 US: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 140
10.2.2 CANADA 140
10.2.2.1 Increasing government initiatives targeted toward stem cell research to drive market growth 140
TABLE 121 CANADA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 141
TABLE 122 CANADA: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 141
TABLE 123 CANADA: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 142
TABLE 124 CANADA: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 142
10.3 EUROPE 143
TABLE 125 EUROPE: CELL ANALYSIS MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 143
TABLE 126 EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 144
TABLE 127 EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 144
TABLE 128 EUROPE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 145
TABLE 129 EUROPE: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 145
10.3.1 GERMANY 146
10.3.1.1 Strong R&D infrastructure, training, and awareness programs ensure market growth in Germany 146
TABLE 130 GERMANY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 146
TABLE 131 GERMANY: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 147
TABLE 132 GERMANY: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 147
TABLE 133 GERMANY: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 148
10.3.2 FRANCE 148
10.3.2.1 Presence of large biotechnology industry favors market growth 148
TABLE 134 FRANCE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 149
TABLE 135 FRANCE: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 149
TABLE 136 FRANCE: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 150
TABLE 137 FRANCE: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 150
10.3.3 UK 151
10.3.3.1 Growing acceptance of flow cytometry products for clinical diagnostics to drive market growth 151
TABLE 138 UK: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 151
TABLE 139 UK: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 152
TABLE 140 UK: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 152
TABLE 141 UK: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 153
10.3.4 ITALY 153
10.3.4.1 Increasing research activities and conferences to
support market growth 153
TABLE 142 ITALY: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 153
TABLE 143 ITALY: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 154
TABLE 144 ITALY: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 154
TABLE 145 ITALY: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 155
10.3.5 SPAIN 155
10.3.5.1 Growing focus on cancer diagnosis increased flow cytometry product usage in Spain 155
TABLE 146 SPAIN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 156
TABLE 147 SPAIN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 156
TABLE 148 SPAIN: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 157
TABLE 149 SPAIN: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 157
10.3.6 REST OF EUROPE 157
TABLE 150 REST OF EUROPE: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 158
TABLE 151 REST OF EUROPE: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 158
TABLE 152 REST OF EUROPE: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 159
TABLE 153 REST OF EUROPE: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 159
10.4 ASIA PACIFIC 160
FIGURE 24 ASIA PACIFIC: CELL ANALYSIS MARKET SNAPSHOT 160
TABLE 154 ASIA PACIFIC: CELL ANALYSIS MARKET, BY COUNTRY,
2020–2027 (USD MILLION) 161
TABLE 155 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 161
TABLE 156 ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 162
TABLE 157 ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 162
TABLE 158 ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 163
10.4.1 JAPAN 163
10.4.1.1 Easy access to technologically advanced cell analysis products to favor market growth 163
TABLE 159 JAPAN: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 163
TABLE 160 JAPAN: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 164
TABLE 161 JAPAN: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 164
TABLE 162 JAPAN: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 165

10.4.2 CHINA 165
10.4.2.1 Developments in biotechnology sector to support market growth 165
TABLE 163 CHINA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 165
TABLE 164 CHINA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 166
TABLE 165 CHINA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 166
TABLE 166 CHINA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 167
10.4.3 INDIA 167
10.4.3.1 Government initiatives to drive market growth in India 167
TABLE 167 INDIA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 167
TABLE 168 INDIA: CELL ANALYSIS MARKET, BY TECHNIQUE, 2020–2027 (USD MILLION) 168
TABLE 169 INDIA: CELL ANALYSIS MARKET, BY PROCESS, 2020–2027 (USD MILLION) 168
TABLE 170 INDIA: CELL ANALYSIS MARKET, BY END USER, 2020–2027 (USD MILLION) 169
10.4.4 REST OF ASIA PACIFIC 169
TABLE 171 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 169
TABLE 172 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 170
TABLE 173 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 170
TABLE 174 REST OF ASIA PACIFIC: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 171
10.5 LATIN AMERICA 171
10.5.1 GROWING PARTICIPATION OF ACADEMIC INSTITUTES IN RESEARCH TO ACCELERATE MARKET GROWTH 171
TABLE 175 LATIN AMERICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE,
2020–2027 (USD MILLION) 172
TABLE 176 LATIN AMERICA: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 172
TABLE 177 LATIN AMERICA: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 173
TABLE 178 LATIN AMERICA: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 173
10.6 MIDDLE EAST & AFRICA 174
10.6.1 GROWING RESEARCH ACTIVITIES WILL FUEL DEMAND FOR
CELL ANALYSIS PRODUCTS 174
TABLE 179 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PRODUCT & SERVICE, 2020–2027 (USD MILLION) 174
TABLE 180 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY TECHNIQUE,
2020–2027 (USD MILLION) 175
TABLE 181 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY PROCESS,
2020–2027 (USD MILLION) 175
TABLE 182 MIDDLE EAST & AFRICA: CELL ANALYSIS MARKET, BY END USER,
2020–2027 (USD MILLION) 176

11 COMPETITIVE LANDSCAPE 177
11.1 INTRODUCTION 177
11.2 RIGHT-TO-WIN APPROACHES ADOPTED BY KEY PLAYERS 177
FIGURE 25 CELL ANALYSIS MARKET: STRATEGIES ADOPTED 178
11.3 MARKET SHARE ANALYSIS 178
FIGURE 26 CELL ANALYSIS MARKET SHARE ANALYSIS (2021) 179
11.4 REVENUE SHARE ANALYSIS (TOP 7 MARKET PLAYERS) 180
FIGURE 27 REVENUE ANALYSIS FOR KEY COMPANIES, 2018–2021 180
11.5 COMPANY EVALUATION QUADRANT 181
11.5.1 STARS 181
11.5.2 EMERGING LEADERS 181
11.5.3 PERVASIVE PLAYERS 181
11.5.4 PARTICIPANTS 182
FIGURE 28 CELL ANALYSIS MARKET: COMPANY EVALUATION MATRIX, 2021 182
11.6 COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/ SMES/
START-UPS (2021) 183
11.6.1 PROGRESSIVE COMPANIES 183
11.6.2 STARTING BLOCKS 183
11.6.3 RESPONSIVE COMPANIES 183
11.6.4 DYNAMIC COMPANIES 183
FIGURE 29 CELL ANALYSIS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR SMES/START-UPS, 2021 184
11.7 COMPETITIVE SCENARIO AND TRENDS 185
11.7.1 PRODUCT LAUNCHES 185
TABLE 183 CELL ANALYSIS MARKET: PRODUCT LAUNCHES 185
11.7.2 DEALS 186
TABLE 184 CELL ANALYSIS MARKET: DEALS 186
11.7.3 OTHER DEVELOPMENTS 186
TABLE 185 CELL ANALYSIS MARKET: OTHER DEVELOPMENTS 186
12 COMPANY PROFILES 187
12.1 KEY COMPANIES 187
(Business Overview, Products Offered, Recent Developments, and MnM View)*
12.1.1 THERMO FISHER SCIENTIFIC INC. 187
TABLE 186 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 187
FIGURE 30 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2020) 188
TABLE 187 THERMO FISHER SCIENTIFIC INC.: PRODUCT OFFERINGS 188
TABLE 188 THERMO FISHER SCIENTIFIC: PRODUCT LAUNCH 189
TABLE 189 THERMO FISHER SCIENTIFIC INC.: DEALS 189
12.1.2 DANAHER 191
TABLE 190 DANAHER: BUSINESS OVERVIEW 191
FIGURE 31 DANAHER: COMPANY SNAPSHOT (2021) 192
TABLE 191 DANAHER: PRODUCT OFFERINGS 192
TABLE 192 DANAHER: DEALS 193
TABLE 193 DANAHER: OTHER DEVELOPMENTS 194
12.1.3 BECTON, DICKINSON AND COMPANY (BD) 195
TABLE 194 BD: BUSINESS OVERVIEW 195
FIGURE 32 BD: COMPANY SNAPSHOT (2021) 196
TABLE 195 BD: PRODUCT OFFERINGS 196
TABLE 196 BD: PRODUCT LAUNCH 198
12.1.4 GENERAL ELECTRIC 199
TABLE 197 GE: BUSINESS OVERVIEW 199
FIGURE 33 GE: COMPANY SNAPSHOT (2021) 200
TABLE 198 GE: PRODUCT OFFERINGS 200
TABLE 199 GE HEALTHCARE: OTHER DEVELOPMENTS 201
12.1.5 MERCK KGAA 202
TABLE 200 MERCK KGAA: BUSINESS OVERVIEW 202
FIGURE 34 MERCK KGAA: COMPANY SNAPSHOT (2021) 203
TABLE 201 MERCK KGAA: PRODUCT OFFERINGS 203
TABLE 202 MERCK KGAA: DEALS 204
12.1.6 AGILENT TECHNOLOGIES, INC. 205
TABLE 203 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW 205
FIGURE 35 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2021) 206
TABLE 204 AGILENT TECHNOLOGIES, INC.: PRODUCT OFFERINGS 206
TABLE 205 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES 207
12.1.7 BIO-RAD LABORATORIES, INC. 208
TABLE 206 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW 208
FIGURE 36 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2021) 209
TABLE 207 BIO-RAD LABORATORIES, INC.: PRODUCT OFFERINGS 209
TABLE 208 BIO-RAD LABORATORIES, INC.: DEALS 210
12.1.8 FLUIDIGM CORPORATION 211
TABLE 209 FLUIDIGM CORPORATION: BUSINESS OVERVIEW 211
FIGURE 37 FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2021) 211
TABLE 210 FLUIDIGM CORPORATION: PRODUCT OFFERINGS 212
TABLE 211 FLUIDIGM CORPORATION: DEALS 213
12.1.9 MILTENYI BIOTEC 214
TABLE 212 MILTENYI BIOTEC: BUSINESS OVERVIEW 214
TABLE 213 MILTENYI BIOTEC: PRODUCT OFFERINGS 214
TABLE 214 MILTENYI BIOTEC: PRODUCT LAUNCHES 215
12.1.10 OLYMPUS CORPORATION 216
TABLE 215 OLYMPUS CORPORATION: BUSINESS OVERVIEW 216
FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2021) 216
TABLE 216 OLYMPUS CORPORATION: PRODUCT OFFERINGS 217

12.1.11 BIOSTATUS LIMITED 218
TABLE 217 BIOSTATUS LIMITED: BUSINESS OVERVIEW 218
TABLE 218 BIOSTATUS LIMITED: PRODUCT OFFERINGS 218
12.1.12 NANOCELLECT BIOMEDICAL 219
TABLE 219 NANOCELLECT BIOMEDICAL: BUSINESS OVERVIEW 219
TABLE 220 NANOCELLECT BIOMEDICAL: PRODUCT OFFERINGS 219
TABLE 221 NANOCELLECT BIOMEDICAL: DEALS 220
TABLE 222 NANOCELLECT BIOMEDICAL: PRODUCT LAUNCH 221
12.1.13 CELL BIOLABS, INC. 222
TABLE 223 CELL BIOLABS, INC: BUSINESS OVERVIEW 222
TABLE 224 CELL BIOLABS, INC.: PRODUCT OFFERINGS 222
12.1.14 CREATIVE BIOARRAY 224
TABLE 225 CREATIVE BIOARRAY: BUSINESS OVERVIEW 224
12.1.15 MEIJI TECHNO 225
TABLE 226 MEIJI TECHNO: BUSINESS OVERVIEW 225
* Business Overview, Products Offered, Recent Developments, and MnM View might not be captured in case of unlisted companies.
12.2 OTHER PLAYERS 226
12.2.1 PROMEGA CORPORATION 226
TABLE 227 PROMEGA CORPORATION: COMPANY OVERVIEW 226
12.2.2 PERKINELMER 226
TABLE 228 PERKINELMER: COMPANY OVERVIEW 226
12.2.3 TECAN TRADING AG 227
TABLE 229 TECAN TRADING AG: COMPANY OVERVIEW 227
12.2.4 CARL ZEISS 227
TABLE 230 CARL ZEISS: COMPANY OVERVIEW 227
12.2.5 SYSMEX AMERICA, INC. 228
TABLE 231 SYSMEX AMERICA, INC.: COMPANY OVERVIEW 228
12.2.6 CELLINK 228
TABLE 232 CELLINK: COMPANY OVERVIEW 228
12.2.7 QIAGEN 228
TABLE 233 QIAGEN: COMPANY OVERVIEW 228
12.2.8 ILLUMINA, INC. 229
TABLE 234 ILLUMINA, INC.: COMPANY OVERVIEW 229
12.2.9 CORNING INCORPORATED 229
TABLE 235 CORNING INCORPORATED: COMPANY OVERVIEW 229
12.2.10 10X GENOMICS 229
TABLE 236 10X GENOMICS: COMPANY OVERVIEW 229

13 APPENDIX 230
13.1 DISCUSSION GUIDE 230
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 233
13.3 AVAILABLE CUSTOMIZATIONS 235
13.4 RELATED REPORTS 235
13.5 AUTHOR DETAILS 236

ページTOPに戻る

Table of Contents

Summary

The global cell analysis market is projected to reach USD 28.6 Billion by 2027 from USD 17.7 Billion in 2022, at a CAGR of 10.1% during the forecast period. Key opportunities for the cell analysis market include, emerging economies, high risk of communicable diseases and pandemic outbreak, and increasing adoption of novel cellular assays in various cancer research applications. On the other hand,high costs associated with cell analysis instruments along with limitations on the usage of reagents for experiments is expected to restrain the market growth.

“The reagents & consumables segment dominates the cell analysis market through the study period of 2020-2027.”

Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The reagents & consumables segment represented largest market share for the year 2021, in cell analysis market. Development of affordable reagent solutions by key market players is the key attributive factor to the segment’s dominance. This is further supplemented by increasing demand for novel cell analysis reagents & consumables in flow cytometry experiments.

“The high content screening (HCS) segment will witness the highest growth in the cell analysis market during the forecast period.”

Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening (HCS), and other techniques. HCS techniquecombineshigh-throughput automated imaging with analysis which helps inthe extraction of single-cell data, multi-parametric in nature. In addition, widening applications of HCS have contributed to the robust CAGR registered by this segment from 2022-2027.

“North America dominated the cell analysis market in 2021.”
Geographically, the cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2021, North America accounted for the largest share of the cell analysis market. North America harbors majority of the key market players leading to maturity of cell analysis market in this region. Also, robust government support for academic & research activities offer opportunity for the key market players to introduce cutting-edge cell analysis products, further intensifying regional market competition.
The primary interviews conducted for this report can be categorized as follows:
• By Company Type -Tier 1: 37%, Tier 2: 23%,and Tier 3: 40%
• By Designation - C-level:32%, D-level:26%, and Others:42%
• By Region - North America:35%, Europe:25%, Asia Pacific:20%, Latin America: 12%, and the Middle East and Africa: 8%
List of Companies Profiled in the Report
• Danaher (US)
• Thermo Fisher Scientific (US)
• BectonDickinson and Company (US)
• General Electric (US)
• Merck KGaA (US)
• Agilent Technologies (US)
• Olympus Corporation (Japan)
• MiltenyiBiotec (US)
• Bio-Rad Laboratories (US)
• BioStatus Limited (UK)
• Fluidigm Corporation (US)
• NanoCellect Biomedical (US)
• Cell Biolabs (US)
• Creative Bioarray (US)
• Meiji Techno (US)
• Promega Corporation (US)
• PerkinElmer (US)
• Tecan Trading AG (Switzerland)
• CELLINK (US)
• QIAGEN (Germany)
• Corning Incorporated (US)
• 10x Genomics (US)
• Illumina (US)

Research Coverage:
This report provides a detailed picture of the global cell analysis market. It aims at estimating the size and future growth potential of the market across different segments, such as product& service,technique, process, end user,and region. The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total cell analysis market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:
The report provides insights on the following pointers:
• Market Penetration: Comprehensive information on cell analysis offered by the top 25 players in the cell analysis market. The report analyses the cell analysis market by product& service,technique, process, end user, and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various cell analysis across key geographic regions.

• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the cell analysis market.

• Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the cell analysis market.

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（バイオマス）の最新刊レポート

MarketsandMarkets社のバイオマス分野での最新刊レポート

本レポートと同じKEY WORD（biotechnology）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野（バイオマス）の最新刊レポート

MarketsandMarkets社のバイオマス分野での最新刊レポート

本レポートと同じKEY WORD（biotechnology）の最新刊レポート

よくあるご質問

MarketsandMarkets社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?